ACIU - AC Immune SA

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.0 0.06 (2.0%)	0.0 (0.0%)	0.0 (0.0%)	0.01 (0.33%)	0.0 (0.0%)	0.06 (2.0%)	-0.01 (-0.41%)	-0.17 (-5.36%)

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Category: /stock/categories/na

Market Period: Market

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 60.0
VWAP:: 3.06
RVol:: 0.7295

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	3.0 -0.05 (-1.64%)	Oct 15 11:05
10m	Price increase 10m	3.12 +0.1 (+3.31%)	Oct 15 10:39
1m	Price decrease 1m	3.04 -0.04 (-1.34%)	Oct 15 10:38
1m	Price increase 1m	3.01 +0.03 (+1.07%)	Oct 15 09:56
1m	Price decrease 1m	2.92 -0.06 (-2.01%)	Oct 15 09:51